View Item 

Show simple item record

Subcutaneous Epcoritamab Induces Deep, Durable Complete Remissions In Relapsed/Refractory Large B-Cell Lymphoma: Longer Follow-Up From The Pivotal Epcore Nhl-1 Trial
dc.contributor.authorThieblemont, C.
dc.contributor.authorKarimi, Y.
dc.contributor.authorJurczak, W.
dc.contributor.authorCheah, C. Y.
dc.contributor.authorClausen, M. R.
dc.contributor.authorCunningham, D.
dc.contributor.authorDo, Y. R.
dc.contributor.authorLewis, D. J.
dc.contributor.authorGasiorowski, R.
dc.contributor.authorKim, T. M.
dc.contributor.authorPoel, M.
dc.contributor.authorPoon, M. L.
dc.contributor.authorFeldman, T.
dc.contributor.authorLinton, K. M.
dc.contributor.authorSureda, A.
dc.contributor.authorHutchings, M.
dc.contributor.authorCottereau, A.
dc.contributor.authorAl Tabaa, Y.
dc.contributor.authorStirner, M. Cota
dc.contributor.authorLiu, Y.
dc.contributor.authorKilavuz, N.
dc.contributor.authorSacchi, M.
dc.contributor.authorLugtenburg, P.
dc.contributor.authorGhesquieres, H.
dc.date.accessioned2023-07-14T13:53:58Z
dc.date.available2024-07-14 09:53:57en
dc.date.available2023-07-14T13:53:58Z
dc.date.issued2023-06
dc.identifier.citationThieblemont, C.; Karimi, Y.; Jurczak, W.; Cheah, C. Y.; Clausen, M. R.; Cunningham, D.; Do, Y. R.; Lewis, D. J.; Gasiorowski, R.; Kim, T. M.; Poel, M.; Poon, M. L.; Feldman, T.; Linton, K. M.; Sureda, A.; Hutchings, M.; Cottereau, A.; Al Tabaa, Y.; Stirner, M. Cota; Liu, Y.; Kilavuz, N.; Sacchi, M.; Lugtenburg, P.; Ghesquieres, H. (2023). "Subcutaneous Epcoritamab Induces Deep, Durable Complete Remissions In Relapsed/Refractory Large B-Cell Lymphoma: Longer Follow-Up From The Pivotal Epcore Nhl-1 Trial." Hematological Oncology 41: 142-144.
dc.identifier.issn0278-0232
dc.identifier.issn1099-1069
dc.identifier.urihttps://hdl.handle.net/2027.42/177201
dc.publisherWiley Periodicals, Inc.
dc.titleSubcutaneous Epcoritamab Induces Deep, Durable Complete Remissions In Relapsed/Refractory Large B-Cell Lymphoma: Longer Follow-Up From The Pivotal Epcore Nhl-1 Trial
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelOphthalmology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/177201/1/hon94_3163.pdf
dc.identifier.doi10.1002/hon.3163_94
dc.identifier.sourceHematological Oncology
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hon94_3163.pdf
Size:
246.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe its collections in a way that respects the people and communities who create, use, and are represented in them. We encourage you to Contact Us anonymously if you encounter harmful or problematic language in catalog records or finding aids. More information about our policies and practices is available at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.